NEW YORK (GenomeWeb News) – Suregene said last week that it has received a $497,000 grant from the National Institute of Mental Health to develop a test for the early detection of schizophrenia.

According to the company, the test focuses on two genetic variations observed in some patients with the mental disorder. The company hopes the test will allow physicians to gauge the risk of a patient developing schizophrenia, as well as help with the development of personalized therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.